title: Is liver disease an octreotide side effect?
authors.forename: Oya
authors.initials: O
authors.lastname: Uygur-Bayramiçli
authors.forename: Cengiz
authors.initials: C
authors.lastname: Gemici
mesh_terms: D000328:Adult; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D002166:Camptothecin / Q000008:administration & dosage / Q000031:analogs & derivatives*; D006528:Carcinoma, Hepatocellular / Q000188:drug therapy; D004334:Drug Administration Schedule; D005260:Female; D005472:Fluorouracil / Q000008:administration & dosage; D005765:Gastrointestinal Agents / Q000008:administration & dosage / Q000009:adverse effects*; D006801:Humans; D000077146:Irinotecan; D002955:Leucovorin / Q000008:administration & dosage; D008113:Liver Neoplasms / Q000188:drug therapy; D015282:Octreotide / Q000008:administration & dosage / Q000009:adverse effects*
chemical_list: D005765:Gastrointestinal Agents; D000077146:Irinotecan; D002955:Leucovorin; D015282:Octreotide; D005472:Fluorouracil; D002166:Camptothecin